Pediatric oncology: regulatory initiatives.

Pediatric priorities: legislative and regulatory initiatives to expand research on the use of medicines in pediatric patients.

Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology.

The discipline of Adolescent and Young Adult (AYA) Oncology addresses compelling medical and psychosocial needs of AYA patients across the spectrum of cancer survivorship. To be successful, extraordinary collaboration involving multiple scientific disciplines and specialties is required. While AYA Oncology is international in scope, recent AYA-focused studies conducted in the Children's Oncolog...

Pediatric Hodgkin Lymphoma.

Hodgkin lymphoma (HL) is one of the most curable pediatric and adult cancers, with long-term survival rates now exceeding 90% after treatment with chemotherapy alone or combined with radiotherapy (RT). Of note, global collaboration in clinical trials within cooperative pediatric HL study groups has resulted in continued progress; however, survivors of pediatric HL are at high risk of potentiall...

Brief report on pediatric oncology in Bangladesh

Cancer in children is emerging as a significant threat to life as deaths from infections and malnutrition have begun to decrease due to concerted maternal and child health initiatives. Efforts are being made to create a comprehensive service for children with Cancer. The major challenges to be overcome are professional and public awareness, late diagnosis, perceptions of incurablity, treatment ...

New initiatives aim to test more cancer drugs for children.

Since the 1970s, the mortality rate for children and adolescents with cancer has dropped by almost 50%, but the cure rate for pediatric cancer has plateaued in the past several years because there are relatively few new drugs being tested for childhood cancers, says Joseph Simone, M.D., professor emeritus of medicine and pediatrics at the Huntsman Cancer Institute at the University of Utah in S...